These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 16880481)

  • 1. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
    Post RM; Altshuler LL; Leverich GS; Frye MA; Nolen WA; Kupka RW; Suppes T; McElroy S; Keck PE; Denicoff KD; Grunze H; Walden J; Kitchen CM; Mintz J
    Br J Psychiatry; 2006 Aug; 189():124-31. PubMed ID: 16880481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
    Frye MA; Helleman G; McElroy SL; Altshuler LL; Black DO; Keck PE; Nolen WA; Kupka R; Leverich GS; Grunze H; Mintz J; Post RM; Suppes T
    Am J Psychiatry; 2009 Feb; 166(2):164-72. PubMed ID: 19015231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
    Post RM; Altshuler LL; Frye MA; Suppes T; Rush AJ; Keck PE; McElroy SL; Denicoff KD; Leverich GS; Kupka R; Nolen WA
    Bipolar Disord; 2001 Oct; 3(5):259-65. PubMed ID: 11912569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM; Leverich GS; Nolen WA; Kupka RW; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck P; Grunze H; Walden J;
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
    Altshuler LL; Post RM; Hellemann G; Leverich GS; Nolen WA; Frye MA; Keck PE; Kupka RW; Grunze H; McElroy SL; Sugar CA; Suppes T
    J Clin Psychiatry; 2009 Apr; 70(4):450-7. PubMed ID: 19358785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    Rush AJ; Trivedi MH; Wisniewski SR; Stewart JW; Nierenberg AA; Thase ME; Ritz L; Biggs MM; Warden D; Luther JF; Shores-Wilson K; Niederehe G; Fava M;
    N Engl J Med; 2006 Mar; 354(12):1231-42. PubMed ID: 16554525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
    Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
    J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.
    Yatham LN; Arumugham SS; Kesavan M; Ramachandran K; Murthy NS; Saraf G; Ouyang Y; Bond DJ; Schaffer A; Ravindran A; Ravindran N; Frey BN; Daigneault A; Beaulieu S; Lam RW; Kondapuram N; Reddy MS; Bhandary RP; Ashok MV; Ha K; Ahn YM; Milev R; Wong H; Reddy YCJ;
    N Engl J Med; 2023 Aug; 389(5):430-440. PubMed ID: 37530824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
    Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
    Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME
    N Engl J Med; 2007 Apr; 356(17):1711-22. PubMed ID: 17392295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
    Vanderkooy JD; Kennedy SH; Bagby RM
    Can J Psychiatry; 2002 Mar; 47(2):174-80. PubMed ID: 11926080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison.
    Altshuler LL; Sugar CA; McElroy SL; Calimlim B; Gitlin M; Keck PE; Aquino-Elias A; Martens BE; Fischer EG; English TL; Roach J; Suppes T
    Am J Psychiatry; 2017 Mar; 174(3):266-276. PubMed ID: 28135846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
    Amsterdam JD; Garcia-España F
    J Affect Disord; 2000 Sep; 59(3):225-9. PubMed ID: 10854639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.
    Segraves RT; Kavoussi R; Hughes AR; Batey SR; Johnston JA; Donahue R; Ascher JA
    J Clin Psychopharmacol; 2000 Apr; 20(2):122-8. PubMed ID: 10770448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bupropion with SRIs and venlafaxine.
    Spier SA
    Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less mood switching with venlafaxine?
    Mattes JA
    Am J Psychiatry; 2006 Sep; 163(9):1642; author reply 1642-3. PubMed ID: 16946194
    [No Abstract]   [Full Text] [Related]  

  • 18. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients.
    Erfurth A; Michael N; Stadtland C; Arolt V
    Neuropsychobiology; 2002; 45 Suppl 1():33-6. PubMed ID: 11893875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline and venlafaxine: new indication. Prevention of recurrent depression: no advance.
    Prescrire Int; 2005 Feb; 14(75):19-20. PubMed ID: 15751171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
    Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.